(Q28212108)

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Neurodegeneration: a failure of neuroregeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Pathological glial tau accumulations in neurodegenerative disease: review and case report

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Cellular prion protein transduces neuroprotective signals

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Oxidative stress and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Epidemiological methods for studying genes and environmental factors in complex diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

1 reference

7 January 2021

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Dietary intake of antioxidants and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

A portrait of Alzheimer secretases--new features and familiar faces

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Neurodegeneration in the age of molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

A unifying hypothesis of Alzheimer's disease. III. Risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Molecular findings in familial Parkinson disease in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Evaluation of multiple presenilin 2 SNPs for association with early-onset sporadic Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Segregation analysis of Parkinson disease revealing evidence for a major causative gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Recent advances in the genetics and pathogenesis of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Huntington disease: new insights into the relationship between CAG expansion and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

The amyloid precursor protein locus and very-late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Shattuck lecture--neurodegenerative diseases and prions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Treatment interventions for Parkinson's disease: an evidence based assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Presenilin, Notch, and the genesis and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Heritable trinucleotide repeats and neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Molecular and cell biological aspects of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Parkinson disease: etiology, pathogenesis and future of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Therapeutic options for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Genes and susceptible loci of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Toxic proteins in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Huntington's disease: the challenge for cell biologists

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Ethics of preimplantation diagnosis for a woman destined to develop early-onset Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Preimplantation diagnosis for early-onset Alzheimer disease caused by V717L mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Complex relationship between Parkin mutations and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Recent developments in neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Defining neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021

Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900196-1

7 January 2021